Comments
Loading...

PharmaCyte Biotech

PMCBNASDAQ
Logo brought to you by Benzinga Data
$1.88
0.15.62%
Last update: 4:37 PM
15 minutes delayed

PharmaCyte Biotech (NASDAQ:PMCB) Stock, Earnings Estimates, EPS, And Revenue

PharmaCyte Biotech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Sep 17
EPS
$1.900
Quarterly Revenue
$0K
Annual Revenue
(as of Jul 31)

Analyze the earnings history of PharmaCyte Biotech using advanced sorting and filters.

Data brought to you by Benzinga APIs

PharmaCyte Biotech (PMCB) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %

PharmaCyte Biotech (PMCB) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is PharmaCyte Biotech (NASDAQ:PMCB) reporting earnings?

A

PharmaCyte Biotech (PMCB) is scheduled to report earnings on December 13, 2024. The last reported earnings were for reported on September 17, 2024 for Q1.

Q

What were the latest earnings per share (EPS) for PharmaCyte Biotech (NASDAQ:PMCB)?

A

The Actual EPS was $1.90, which beat the estimate of $0.00.

Q

What were PharmaCyte Biotech’s (NASDAQ:PMCB) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch